There were 171 press releases posted in the last 24 hours and 357,102 in the last 365 days.

Nanophase Reports Fourth Quarter and Year End 2015 Financial Results

The Company’s Financial Conference Call is Scheduled for February 25, 2016 at 11am EST

ROMEOVILLE, Ill., Feb. 24, 2016 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB:NANX), a technology leader in nanomaterials and advanced nanoengineered products, today reported financial results for the fourth quarter and fiscal year ended December 31, 2015. 

Nanophase CEO and President Jess Jankowski commented, “Our increase in revenue all dropped to the bottom line, which indicates that we continue to create efficiencies.  We bounced back from a tough first half to show positive cash generation during the second half of 2015.  We expect to be even stronger in 2016.” 

Fourth Quarter 2015 Financial Highlights

  • Revenue for the fourth quarter was $2.3 million, vs. the $1.8 million reported during the fourth quarter of 2014. 
     
  • The net loss for the quarter was $0.3 million, or a loss of $0.01 per share, compared to a net loss of $0.9 million, or $0.03 per share, for the comparable 2014 quarter. 
     
  • The Company finished the quarter with approximately $1.3 million in cash and cash equivalents; the Company has no debt.  The Company enhanced its cash position on February 10, 2016, by selling 2.6 million shares of unregistered common stock to its largest investor at $0.38 per share, for $988,000 in proceeds. 


Fiscal Year 2015 Financial Highlights

  • Revenue for fiscal year 2015 was $10.3 million, vs. $9.9 million in fiscal year 2014. 
     
  • The net loss for the year ended December 31, 2015 was $1.2 million, or a loss of $0.04 per share, compared to a net loss of $1.7 million, or $0.06 per share, for the comparable 2014 period. 


Jankowski continued, “Throughout 2015 we discussed looking at potentially raising a small amount of money, but doing so prudently depending on the opportunity and cost.  We found such an opportunity during February 2016, raising equity capital for the first time since 2012.  Our business has seen plenty of misses to go along with our wins, but overall our focused approach is driving significant operational and product development improvements.  We expect to see real top line growth as our new products hit the market.” 

Shareholders and members of the financial community are encouraged to participate in the upcoming conference call, where Mr. Jankowski will discuss the company’s current and long-term prospects.

In addition to tomorrow’s call, Nanophase has also added an investor news summary to its website to highlight some of its current marketing activities that may be of interest (www.nanophase.com, under Investor Relations >> Investor News >> Q4 Investor Recap).

Fourth Quarter 2015 Conference Call
The Nanophase conference call, to be hosted by Jess Jankowski, the Company’s President & CEO, is scheduled for February 25, 2016, at 10:00 a.m. CST, 11:00 a.m. EST. The conference call dial-in number for U.S. callers is 877-312-8776 and for international callers is 408-774-4007.  The conference ID is 50070834.  Please dial in to the conference at least five minutes before the call is scheduled to begin.

A webcast of the event may be accessed through the company’s website, at www.nanophase.com, by clicking on Investor Relations, Investor News and the link in the February 25th conference call announcement release.

Use of Non-GAAP Financial Information
Nanophase believes that the presentation of results excluding certain items, such as non-cash equity compensation charges, provides meaningful supplemental information to both management and investors, facilitating the evaluation of performance across reporting periods. The Company uses these non-GAAP measures for internal planning and reporting purposes. These non-GAAP measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP measures used by other companies. The presentation of this additional information is not meant to be considered in isolation or as a substitute for net income or net income per share prepared in accordance with generally accepted accounting principles.

About Nanophase Technologies
Nanophase Technologies Corporation (NANX), www.nanophase.com, is a leader in nanomaterials technologies and provides nanoengineered solutions for multiple industrial product applications. Using a platform of patented and proprietary integrated nanomaterial technologies, the Company creates products with unique performance attributes from two ISO 9001:2008 and ISO 14001 facilities. Nanophase delivers commercial quantity and quality nanoparticles, coated nanoparticles, and nanoparticle dispersions in a variety of media. 

Forward-Looking Statements
This press release contains words such as “expects,” ”shall,” “will,” “believes,” and similar expressions that are intended to identify forward-looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Such statements in this announcement are made based on the Company’s current beliefs, known events and circumstances at the time of publication, and as such, are subject in the future to unforeseen risks and uncertainties that could cause the Company’s results of operations, performance and achievements to differ materially from current expectations expressed in, or implied by, these forward-looking statements. These risks and uncertainties include, without limitation, the following: its ability to become profitable despite the losses it has incurred since incorporation; dependence on its principal customers and the terms of the supply agreement with BASF which could trigger a requirement to transfer technology and/or sell equipment to that customer; the potential inability to obtain working capital when needed on acceptable terms or at all; the ability to obtain materials at costs that can be passed through to customers, including Rare Earth elements, specifically cerium oxide; a decision by a customer to cancel a purchase order or supply agreement in light of the Company’s dependence on a limited number of key customers; uncertain demand for, and acceptance of, the Company’s nanocrystalline materials; the Company’s manufacturing capacity and product mix flexibility in light of customer demand; the Company’s limited marketing experience; changes in development and distribution relationships; the impact of competitive products and technologies; the Company’s dependence on patents and protection of proprietary information; the resolution of litigation or other legal proceedings in which the Company may become involved; the impact of any potential new government regulations that could be difficult to respond to or too costly to comply with while remaining financially viable; the ability of the Company to maintain an appropriate electronic trading venue for its securities; and other factors described in the Company’s Form 10-K filed March 27, 2015. In addition, the Company’s forward-looking statements could be affected by general industry and market conditions and growth rates. Except as required by federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events, uncertainties or other contingencies.



NANOPHASE TECHNOLOGIES CORPORATION
           
BALANCE SHEETS
           
           
       December 31,    
        2015      December 31,
ASSETS (Unaudited)     2014  
           
Current assets:      
  Cash and cash equivalents $   1,275,402     $   1,861,524  
  Trade accounts receivable, less allowance for doubtful accounts      
    of $6,000 on December 31, 2015 and December 31, 2014     506,549         387,760  
  Other receivable     43          65  
  Inventories, net     661,593         950,106  
  Prepaid expenses and other current assets     247,726         367,860  
    Total current assets     2,691,313          3,567,315  
           
  Equipment and leasehold improvements, net     1,860,579         2,137,549  
  Other assets, net     22,381         24,864  
      $   4,574,273     $   5,729,728  
           
LIABILITIES AND STOCKHOLDERS' EQUITY      
Current liabilities:      
  Current portion of capital lease obligations $   94,406     $   69,733  
  Accounts payable     507,643          492,718  
  Accrued expenses     276,287         412,824  
    Total current liabilities     878,336         975,275  
           
  Long-term portion of capital lease obligations     143,560         120,787  
  Long-term deferred rent     518,747         621,475  
  Asset retirement obligation     172,238         166,099  
    Total long-term liabilities      834,545         908,361  
           
           
Stockholders' equity:      
  Preferred stock, $.01 par value, 24,088 shares authorized and      
    no shares issued and outstanding     -       
  Common stock, $.01 par value, 35,000,000 shares authorized; 28,585,496         -  
    and 28,516,163 shares issued and outstanding on December 31, 2015 and      
    December 31, 2014, respectively     285,855         285,162  
  Additional paid-in capital     96,172,795         95,965,739  
  Accumulated deficit     (93,597,258 )       (92,404,809 )
    Total stockholders' equity     2,861,392         3,846,092  
      $    4,574,273     $   5,729,728  

 





NANOPHASE TECHNOLOGIES CORPORATION
                         
STATEMENTS OF OPERATIONS
                         
(Unaudited)
                         
            Three months ended   Years ended
            December 31,   December 31,
              2015       2014       2015       2014  
Revenue:                    
  Product revenue, net     $   2,271,979     $   1,809,271     $   10,271,919     $   9,879,743  
  Other revenue         7,780         10,389         41,270         56,079  
    Net revenue          2,279,759         1,819,660         10,313,189         9,935,822  
                         
Operating expense:                  
  Cost of revenue         1,606,702         1,523,771         7,199,594         7,104,572  
    Gross profit         673,057         295,889         3,113,595         2,831,250  
                         
  Research and development expense         303,193         348,261         1,272,621         1,337,719  
  Selling, general and administrative expense       703,585         824,283         3,019,424         3,215,616  
Loss from operations         (333,721 )       (876,655 )       (1,178,450 )       (1,722,085 )
Interest income         -         -         -         810  
Interest expense         (4,625 )        (1,191 )       (13,999 )       (5,537 )
Other, net           -         -         -         -  
Loss before provision for income taxes         (338,346 )       (877,846 )       (1,192,449 )       (1,726,812 )
Provision for income taxes         -         -         -         -  
Net loss       $   (338,346 )   $   (877,846 )   $   (1,192,449 )   $   (1,726,812 )
                         
                         
Net loss per share- basic and diluted     $   (0.01 )   $   (0.03 )   $    (0.04 )   $   (0.06 )
                         
Weighted average number of basic and diluted                
  common shares outstanding         28,585,496         28,484,511         28,574,902         28,482,256  

 

 



NANOPHASE TECHNOLOGIES CORPORATION
                         
STATEMENTS OF OPERATIONS - EXPANDED SCHEDULE
                         
(Unaudited)
                         
            Three months ended   Years ended
            December 31,   December 31,
              2015       2014       2015       2014  
Revenue:                    
  Product revenue, net     $   2,271,979     $   1,809,271     $   10,271,919     $   9,879,743  
  Other revenue         7,780         10,389         41,270         56,079  
    Net revenue         2,279,759         1,819,660         10,313,189         9,935,822  
                         
Operating expense:                  
  Cost of revenue detail:                  
  Depreciation         147,685          147,695         581,382         597,916  
  Non-Cash equity compensation         5,105         4,981         22,369         24,383  
  Other costs of revenue         1,453,912         1,371,095         6,595,843         6,482,273  
    Cost of revenue         1,606,702         1,523,771         7,199,594         7,104,572  
      Gross profit         673,057         295,889         3,113,595         2,831,250  
                         
  Research and development expense detail:                
  Depreciation         27,475         29,838         113,043          105,920  
  Non-Cash equity compensation         8,279         9,795         34,380         52,307  
  Other research and development expense       267,439         308,628          1,125,198         1,179,492  
    Research and development expense         303,193         348,261         1,272,621         1,337,719  
                         
  Selling, general and administrative expense detail:            
  Depreciation and amortization         10,090         10,090         40,449         39,343  
  Non-Cash equity compensation         27,902         23,392          123,828         110,643  
  Other selling, general and administrative expense     665,593         790,801         2,855,147         3,065,630  
    Selling, general and administrative expense      703,585         824,283         3,019,424         3,215,616  
Loss from operations         (333,721 )       (876,655 )       (1,178,450 )       (1,722,085 )
Interest income          -         -         -         810  
Interest expense         (4,625 )       (1,191 )       (13,999 )       (5,537 )
Other, net            -         -         -         -  
Loss before provision for income taxes         (338,346 )       (877,846 )       (1,192,449 )       (1,726,812 )
Provision for income taxes         -         -         -         -  
Net loss       $   (338,346 )   $   (877,846 )   $   (1,192,449 )   $   (1,726,812 )
                         
Non-GAAP Disclosure (see note regarding Non-GAAP disclosures):            
  Addback Interest, net         4,625         1,191         13,999         4,727  
  Addback Depreciation/Amortization         185,250         187,623         734,874         743,179  
  Addback Non-Cash Equity Compensation         41,286         38,168         180,577         187,333  
                         
  Adjusted EBITDA     $   (107,185 )   $   (650,864 )   $   (262,999 )   $   (791,573 )


 

COMPANY CONTACT
Nancy Baldwin
Investor Relation
630-771-6708

Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.